Chemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte trafficking
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33156620" target="_blank" >RIV/61989592:15110/15:33156620 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Chemokine receptors and their therapeutic opportunities in diseased lung: far beyond leukocyte trafficking
Original language description
Chemokine receptors and their ligands, key mediators of immune cell trafficking, have been critically involved in chronic lung diseases and their potential as therapeutic targets is currently being widely investigated. The discovery that chemokine receptors/chemokines, typically expressed by immune cells, are also expressed in structural lung cells reinforces significantly the evidence about their potential to mediate processes towards the restoration of normal lung functions. Besides cell migration, chemokine receptors and their ligands have been shown to regulate also other functions in the lung tissue, such as cell proliferation, mucin secretion, and collagen synthesis. Thus chemokine receptors/chemokines contribute not only to immune responses in the lung, but play a critical role also in the regulation of lung tissue repair and regeneration. This review aims to summarize current state-of-the-art on chemokine receptors and their ligands in chronic lung diseases and their therapeutic potential. Next, it aims to delineate the contribution of chemokine receptors to the processes leading to repair/regeneration of the lung tissue.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FC - Pneumology
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/NT11117" target="_blank" >NT11117: Study of mediators of fibrotic processes in patients with diffuse lung diseases and their clinical application</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
American journal of physiology. Lung cellular and molecular physiology
ISSN
1522-1504
e-ISSN
—
Volume of the periodical
308
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
16
Pages from-to
"L-603"-"L-618"
UT code for WoS article
—
EID of the result in the Scopus database
—